Primary Care was suppose to blow it out of the water for Tepezza. so what happened? Thought you guys could sell anything.
Earnings Call
- Thread starter anonymous
- Start date
-
- Tags
- None
You mean IBU reps? They were more than primary care...or so they said they were 
I would blame it on all of the reps in that division not just the promoted ones. You have people on a previous thread arguing that dinner promotional programs are worthless in rare disease. Obviously we have people that are clueless in that division as they missed revenue by 100 million dollars. Its not a little miss.
I wonder what Amgen is thinking? Do they get rid of everyone knowing most of it is trash. Or do they try to keep everyone to keep the lights on while slowing replacing them. Not a good place to be. How do they even show success of what they accomplished on in an interview?
I wonder what Amgen is thinking? Do they get rid of everyone knowing most of it is trash. Or do they try to keep everyone to keep the lights on while slowing replacing them. Not a good place to be. How do they even show success of what they accomplished on in an interview?
The majority of the OBU is brand new within the last six months!
Dinner programs are a great tool, when used appropriately, and to the correct audience. Shoving them down peoples throats at the pace of one a month may not be the most effective way to go about it.
The goals set forth for this division do not align with rare disease.
Oh, here we go with the programs. Clearly they aren’t worthless, but they certainly are not essential for success. If you need them so badly, then you are nothing but a good party planner.
massive execution failure from the commercial team. Loss of reps who knew how to see the drug and adding a bunch of losers from the IBU who thought they could sell it but couldn't. Add to it the awful leadership they brought over from the IBU and you have a formula for failure.